Comparison between Lenskart Solutions IPO and Nephrocare Health IPO.
Lenskart Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Nephrocare Health IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Lenskart Solutions IPO is up to ₹7,278.02 Cr whereas the issue size of the Nephrocare Health IPO is up to ₹871.05 Cr. The final issue price of Lenskart Solutions IPO is ₹402.00 per share and of Nephrocare Health IPO is ₹460.00 per share.
| Lenskart Solutions IPO | Nephrocare Health IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹382.00 per share | ₹438.00 per share |
| Issue Price (Upper) | ₹402.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹402.00 per share | ₹460.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹19.00 per share | ₹41.00 per share |
| Market Lot Size | 37 shares | 32 shares |
| Fresh Issue Size | 5,34,95,905 shares | 76,89,918 shares |
| Fresh Issue Size (Amount) | up to ₹2,150.38 Cr | up to ₹353.60 Cr |
| OFS Issue Size | 12,75,62,573 shares | 1,12,53,102 shares |
| OFS Issue Size (Amount) | up to ₹5,127.64 Cr | up to ₹517.45 Cr |
| Issue Size Total | 18,10,58,478 shares | 1,89,43,020 shares |
| Issue Size Total (Amount) | up to ₹7,278.02 Cr | up to ₹871.05 Cr |
Lenskart Solutions IPO opens on Oct 31, 2025, while Nephrocare Health IPO opens on Dec 10, 2025. The closing date of Lenskart Solutions IPO and Nephrocare Health IPO is Nov 04, 2025, and Dec 12, 2025, respectively.
| Lenskart Solutions IPO | Nephrocare Health IPO | |
|---|---|---|
| Anchor Bid Date | Oct 30, 2025 | Dec 09, 2025 |
| Issue Open | Oct 31, 2025 | Dec 10, 2025 |
| Issue Close | Nov 04, 2025 | Dec 12, 2025 |
| Basis Of Allotment (Tentative) | Nov 06, 2025 | Dec 15, 2025 |
| Initiation of Refunds (Tentative) | Nov 07, 2025 | Dec 16, 2025 |
| Credit of Share (Tentative) | Nov 07, 2025 | Dec 16, 2025 |
| Listing date (Tentative) | Nov 10, 2025 | Dec 17, 2025 |
| Anchor Lockin End date 1 | Dec 05, 2025 | Jan 13, 2026 |
| Anchor Lockin End date 2 | Feb 03, 2026 | Mar 14, 2026 |
Lenskart Solutions IPO P/E ratio is 227.27, as compared to Nephrocare Health IPO P/E ratio of 63.52.
| Lenskart Solutions IPO | Nephrocare Health IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Lenskart Solutions Ltd.'s revenue increased by 25% and profit after tax (PAT) rose by 3028% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Nephrocare Health Services Ltd.'s revenue increased by 34% and profit after tax (PAT) rose by 91% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 19.85 | 78.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 17.52 | 71.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 227.27 | 63.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹69727.57 Cr. | ₹4615.34 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.45% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.84 | 18.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.77 | ₹7.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 4.84 | 13.19% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Lenskart Solutions IPO Retail Individual Investors (RII) are offered 1,80,67,202 shares while in Nephrocare Health IPO retail investors are offered 1,80,67,202 shares. Qualified Institutional Buyers (QIB) are offered 5,42,01,608 shares in Lenskart Solutions IPO and 37,71,946 shares in Nephrocare Health IPO.
| Lenskart Solutions IPO | Nephrocare Health IPO | |
|---|---|---|
| Anchor Investor Reservation | 8,13,02,412 shares | 56,57,919 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 5,42,01,608 shares | 37,71,946 shares |
| NII | 2,71,00,803 shares | 28,28,960 shares |
| RII | 1,80,67,202 shares | 66,00,907 shares |
| Employee | 3,91,644 shares | 83,532 shares |
| Others | ||
| Total | 18,10,63,669 shares | 1,89,43,264 shares |
Lenskart Solutions IPO subscribed 28.27x in total, whereas Nephrocare Health IPO subscribed 14.08x.
| Lenskart Solutions IPO | Nephrocare Health IPO | |
|---|---|---|
| QIB (times) | 40.36x | 26.82x |
| NII (times) | 18.23x | 24.77x |
| Big NII (times) | 21.81x | 30.43x |
| Small NII (times) | 11.06x | 13.46x |
| RII (times) | 7.56x | 2.36x |
| Employee (times) | 4.96x | 2.81x |
| Other (times) | ||
| Total (times) | 28.27x | 14.08x |
